Intellia Therapeutics reported revenue of $7.66M and net income of -$107.42M for the quarter ended Jun 2026, down 46.2% year over year. This income statement covers 46 quarters of results from Mar 2015 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Mar2015 | Jun2015 | Sep2015 | Dec2015 | Mar2016 | Jun2016 | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 74.34M | 74.49M | 75.62M | 76.00M | 76.59M | 87.10M | 88.10M | 88.35M | 89.10M | 93.00M | 96.33M | 98.29M | 101.80M | 102.03M | 103.54M | 105.33M | 115.79M | 116.32M | 120.45M | 140.02M | ||||||||||||||||||||||||||
| Revenue & cost | ||||||||||||||||||||||||||||||||||||||||||||||
| Revenue | 7.20M | 12.85M | 11.25M | 14.03M | 13.27M | 13.57M | 12.61M | 13.59M | 11.99M | -1.92M | 28.93M | 6.96M | 9.11M | 12.87M | 16.63M | 14.24M | 13.78M | 23.02M | 15.05M | 7.66M | ||||||||||||||||||||||||||
| Operating items | ||||||||||||||||||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 60.49M | 71.16M | 133.09M | 90.20M | 96.65M | 100.03M | 97.12M | 115.28M | 113.70M | 108.98M | 111.85M | 114.21M | 123.38M | 116.88M | 108.43M | 97.03M | 94.75M | 88.65M | 80.74M | 82.59M | ||||||||||||||||||||||||||
| Selling, General & AdministrativeSG&A | 18.71M | 22.11M | 22.40M | 22.13M | 22.14M | 23.63M | 27.45M | 30.65M | 29.40M | 28.99M | 31.09M | 31.79M | 30.50M | 32.44M | 29.01M | 27.21M | 30.51M | 33.08M | 34.84M | 37.82M | ||||||||||||||||||||||||||
| Other Operating ExpensesOther Opex | 6.07M | 20.35M | 3.06M | -62.05M | 2.12M | -1.34M | -3.44M | 1.75M | 0.90M | -0.33M | ||||||||||||||||||||||||||||||||||||
| Operating ExpensesOpex | 79.20M | 93.27M | 155.50M | 112.33M | 118.80M | 123.66M | 124.56M | 145.93M | 143.10M | 137.97M | 142.94M | 146.00M | 153.88M | 149.32M | 137.43M | 124.24M | 125.26M | 121.73M | 115.58M | 120.42M | ||||||||||||||||||||||||||
| Operating IncomeOp. Inc | -71.99M | -80.42M | -144.25M | -98.30M | -105.53M | -110.09M | -111.96M | -132.33M | -131.11M | -139.89M | -114.00M | -139.04M | -144.77M | -136.45M | -120.81M | -110.00M | -111.48M | -98.71M | -100.53M | -112.76M | ||||||||||||||||||||||||||
| EBIT | -71.99M | -80.42M | -144.25M | -98.30M | -105.53M | -110.09M | -111.96M | -132.33M | -131.11M | -139.89M | -114.00M | -139.04M | -144.77M | -136.45M | -120.81M | -110.00M | -111.48M | -98.71M | -100.53M | -112.76M | ||||||||||||||||||||||||||
| Non-operating items | ||||||||||||||||||||||||||||||||||||||||||||||
| Non Operating Investment Income | -0.16M | -1.95M | -5.13M | -0.93M | 0.99M | 3.43M | 2.99M | -1.48M | 0.14M | 1.99M | -6.07M | -20.35M | 4.45M | -3.08M | -2.12M | 1.34M | 3.44M | -2.65M | -1.27M | -0.79M | ||||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.35M | 0.50M | 0.54M | 0.70M | 1.95M | 5.35M | 11.98M | 12.65M | 12.74M | 12.46M | 12.63M | 12.42M | 12.12M | 10.63M | 8.60M | 7.40M | 6.71M | 6.48M | 5.21M | 5.80M | ||||||||||||||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | 0.35M | -0.82M | -2.63M | -2.38M | -7.70M | -3.32M | 8.83M | 8.65M | 8.88M | 7.73M | 6.57M | -7.93M | 9.06M | 7.55M | 6.48M | 8.74M | 10.15M | 2.92M | 4.30M | 6.13M | ||||||||||||||||||||||||||
| Net income details | ||||||||||||||||||||||||||||||||||||||||||||||
| EBT | -71.64M | -79.91M | -143.71M | -97.60M | -103.58M | -104.73M | -99.98M | -119.68M | -118.37M | -127.43M | -101.37M | -126.62M | -132.65M | -125.82M | -112.20M | -102.59M | -104.76M | -92.23M | -95.33M | -106.96M | ||||||||||||||||||||||||||
| Tax ProvisionsTaxes | ||||||||||||||||||||||||||||||||||||||||||||||
| Profit After TaxPAT | -71.81M | -83.69M | -146.87M | -100.68M | -113.23M | -111.50M | -103.13M | -123.68M | -122.22M | -132.16M | -107.44M | -146.97M | -135.71M | -128.90M | -114.33M | -101.66M | -101.32M | -95.79M | -96.23M | -107.42M | ||||||||||||||||||||||||||
| Equity Income | -1.32M | -2.75M | -3.25M | -1.83M | -3.25M | -3.05M | -4.00M | -3.86M | -4.73M | |||||||||||||||||||||||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -71.64M | -79.91M | -143.71M | -97.60M | -103.58M | -104.73M | -99.98M | -119.68M | -118.37M | -127.43M | -101.37M | -126.62M | -132.65M | -125.82M | -112.20M | -102.59M | -104.76M | -92.23M | -95.33M | -106.96M | ||||||||||||||||||||||||||
| Consolidated Net IncomeConsol Net Inc. | -71.64M | -79.91M | -143.71M | -97.60M | -103.58M | -104.73M | -99.98M | -119.68M | -118.37M | -127.43M | -101.37M | -126.62M | -132.65M | -125.82M | -112.20M | -102.59M | -104.76M | -92.23M | -95.33M | -106.96M | ||||||||||||||||||||||||||
| Income towards Parent CompanyParent Net Inc | -71.64M | -79.91M | -143.71M | -97.60M | -103.58M | -104.73M | -99.98M | -119.68M | -118.37M | -127.43M | -101.37M | -126.62M | -132.65M | -125.82M | -112.20M | -102.59M | -104.76M | -92.23M | -95.33M | -106.96M | ||||||||||||||||||||||||||
| Net Income towards Common StockholdersNet Income | -71.64M | -79.91M | -143.71M | -97.60M | -103.58M | -104.73M | -99.98M | -119.68M | -118.37M | -127.43M | -101.37M | -126.62M | -132.65M | -125.82M | -112.20M | -102.59M | -104.76M | -92.23M | -95.33M | -106.96M | ||||||||||||||||||||||||||
| Additional items | ||||||||||||||||||||||||||||||||||||||||||||||
| EPS (Basic) | -0.97 | -1.13 | -1.92 | -1.29 | -1.36 | -1.36 | -1.14 | -1.36 | -1.34 | -1.44 | -1.06 | -1.31 | -1.31 | -1.27 | -1.08 | -0.99 | -0.95 | -0.85 | -0.80 | -0.80 | ||||||||||||||||||||||||||
| EPS (Diluted) | -0.97 | -1.13 | -1.92 | -1.29 | -1.36 | -1.36 | -1.14 | -1.36 | -1.34 | -1.44 | -1.06 | -1.31 | -1.31 | -1.27 | -1.08 | -0.99 | -0.95 | -0.85 | -0.80 | -0.80 | ||||||||||||||||||||||||||
| Shares Outstanding | 73.71M | 70.89M | 74.75M | 75.82M | 76.05M | 76.97M | 87.77M | 88.19M | 88.64M | 88.77M | 95.50M | 96.97M | 101.00M | 98.85M | 103.50M | 103.73M | 110.19M | 108.38M | 118.49M | 133.48M | ||||||||||||||||||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 73.71M | 70.89M | 74.75M | 75.82M | 76.05M | 76.97M | 87.77M | 88.19M | 88.64M | 88.77M | 95.50M | 96.97M | 101.00M | 98.85M | 103.50M | 103.73M | 110.19M | 108.38M | 118.49M | 133.48M | ||||||||||||||||||||||||||
| EBITDA | -71.99M | -80.42M | -144.25M | -98.30M | -105.53M | -110.09M | -111.96M | -132.33M | -131.11M | -139.89M | -114.00M | -139.04M | -144.77M | -136.45M | -120.81M | -110.00M | -111.48M | -98.71M | -100.53M | -112.76M | ||||||||||||||||||||||||||
| Tax Rate |